...
机译:Genetically engineered fusion of MAP-1 and factor H domains 1-5 generates a potent dual upstream inhibitor of both the lectin and alternative complement pathways
Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Clin Immunol 7631,Lab Mol Med, DK-2100;
complement therapeutics; regulation; chimeric molecules; recombinant protein; inflammation;